Mesolit 600mg Injection 3ml
Key Information
Generic Name
Generic Name Mesna 600 mg
Manufacturer
Neon Laboratories Ltd
Country of Origin
India
Detailed Information
Introduction
INTRODUCTION ABOUT MESOLIT 600MG INJECTIONMESOLIT 600MG INJECTION contains Mesna, which belongs to a group of medicines called Cytoprotective agents. MESOLIT 600MG INJECTION is used to protect the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine. MESOLIT 600MG INJECTION is also used to reduce the risk of bleeding from the bladder when Ifosfamide is used as a chemotherapy drug in affected individuals. MESOLIT 600MG INJECTION is not recommended for use in patients allergic to Mesna. Before receiving MESOLIT 600MG INJECTION, inform your doctor if you have liver problems (such as hepatic impairment), and/or kidney problems (such as renal impairment). MESOLIT 600MG INJECTION is generally not recommended for use during pregnancy and in women planning for pregnancy as it is not known whether the medicine can cause harm to the unborn baby. It is also not recommended for use in breastfeeding women. MESOLIT 600MG INJECTION should be used with caution in children and adolescents (aged below 18 years) only if necessary since it is not known whether the medicine is safe and effective in children. It is also advised to be used with caution in elderly patients (aged 65 years or older) after consulting the doctor. The most common
Uses
OF MESOLIT 600MG INJECTION Protects the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine Reduces the risk of bleeding from the bladder when Ifosfamide is used as a chemotherapy drug in affected individuals
How It Works
MESOLIT 600MG INJECTION works by protecting the lining of the bladder and kidney from by-products of cyclophosphamide and ifosfamide, which get formed in the body after its administration as a chemotherapy medicine in affected individuals.
Directions for Use
MESOLIT 600MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition.
Side Effects
taking MESOLIT 600MG INJECTION are headaches, dizziness, constipation, flu-like symptoms, sore throat, fever, cough, and/or diarrhea. Consult your doctor if any of these symptoms worsen. USES OF MESOLIT 600MG INJECTION Protects the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine Reduces the risk of bleeding from the bladder when Ifosfamide is used as a chemotherapy drug in affected individuals HOW MESOLIT 600MG INJECTION WORKSMESOLIT 600MG INJECTION works by protecting the lining of the bladder and kidney from by-products of cyclophosphamide and ifosfamide, which get formed in the body after its administration as a chemotherapy medicine in affected individuals. DIRECTIONS FOR USEMESOLIT 600MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition. SIDE EFFECTS OF MESOLIT 600MG INJECTIONCOMMON headaches dizziness, constipation, diarrhea flu, sore throat, cough Stop taking MESOLIT 600MG INJECTION and contact your doctor if you experience any of the following side effects: chest pain, rash, and/or itching
Warnings & Precautions
& PRECAUTIONSPREGNANCYMonitoring requiredMESOLIT 600MG INJECTION is generally not recommended for use during pregnancy unless it is clearly necessary. Consult your doctor before receiving the medicine. BREASTFEEDINGContraindicatedMESOLIT 600MG INJECTION is not recommended for use by breastfeeding women. Consult your doctor before receiving the medicine. DRIVING AND USING MACHINESUse with CautionDo not drive or operate machines if you experience syncope, light-headedness, lethargy, drowsiness, dizziness, and/or blurred vision after receiving MESOLIT 600MG INJECTION. KIDNEYUse with CautionMESOLIT 600MG INJECTION should be used with caution in patients with kidney problems, such as renal impairment. Consult your doctor before receiving the medicine. LIVERUse with CautionMESOLIT 600MG INJECTION should be used with caution in patients with liver problems such as hepatic impairment. Consult your doctor before receiving the medicine. ALLERGYContraindicatedDo not receive MESOLIT 600MG INJECTION if you are allergic (hypersensitive) to Mesna and/or any other ingredients of this medicine. USE IN PEDIATRICSConsult your doctorMESOLIT 600MG INJECTION should be used with caution in children and adolescents (aged below 18 years) only if necessary since it is not known whether the medicine is safe and effective in children. Consult your doctor before administering the medicine to the child. USE IN GERIATRICSUse with CautionMESOLIT 600MG INJECTION should be used with caution in elderly patients (aged 65 years or older). Consult your doctor before receiving the medicine. OTHERSBefore receiving MESOLIT 600MG INJECTION, inform your doctor if you: have any other medical conditions
Drug Interactions
SA. Drug-Drug interactions: Before receiving MESOLIT 600MG INJECTION, inform your doctor if you are taking any of the following medicines: oxazaphosphorine, cyclophosphamide, and ifosfamide (anticancer medicines) cytostatics (used to block the growth of cancer cells) Ex. adriamycin, methotrexate, and vincristine Overdosage: MESOLIT 600MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so you are unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms such as nausea, vomiting, abdominal pain, diarrhea, headache, fatigue, limb and joint pains, rash, flushing, low blood pressure, a slow or fast heart, paraesthesia (tingling or numbness in the legs or arms), fever, and/or bronchospasm. SYNOPSIS Drug : Mesna Pharmacological Category : Cytoprotective Agents Therapeutic Indication : Protects bladder and kidneys from cancer chemotherapy (Involving cyclophosphamide and ifosfamide), Reduces risk of bleeding from bladder (when Ifosfamide is used as a chemotherapy drug) Dosage Forms : Injection, Respirator Solution, Respules MORE INFORMATION Keep MESOLIT 600MG INJECTION out of reach of children Store MESOLIT 600MG INJECTION below 30°C
Frequently Asked Questions
Common questions and answers about Mesolit 600mg Injection 3ml.
What is MESOLIT 600MG INJECTION used for?
MESOLIT 600MG INJECTION is used to protect the bladder and kidneys from cancer chemotherapy involving cyclophosphamide and ifosfamide as an anticancer medicine. It is also used to reduce the risk of bleeding from the bladder when ifosfamide is used as a chemotherapy drug in affected individuals.
What are the side effects of taking MESOLIT 600MG INJECTION?
The most common side effects of taking MESOLIT 600MG INJECTION are headaches, dizziness, constipation, flu-like symptoms, sore throat, fever, cough, and/or diarrhea. Consult your doctor if any of these symptoms worsen.
How does MESOLIT 600MG INJECTION work?
MESOLIT 600MG INJECTION works by protecting the lining of the bladder and kidney from by-products of cyclophosphamide and ifosfamide, which get formed in the body after its administration as a chemotherapy medicine in affected individuals.
How is MESOLIT 600MG INJECTION administered?
MESOLIT 600MG INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition.
Can MESOLIT 600MG INJECTION be used for pregnant and breastfeeding women?
No, MESOLIT 600MG INJECTION is generally not recommended for use during pregnancy or in women planning for pregnancy since it is not known whether the medicine may cause harm to the unborn child. It is also not recommended for use by breastfeeding women. Consult your doctor before taking the medicine.
Article Information
Written By
DETAILS Written By Dr. N. Sai Swaroop
Medical Content Writer
Reviewed By
Dr. Sankara Babu Gorle
Medical Expert
Last Updated
17 Feb 2024